Similarly, in colorectal cancer patients, studies have shown that high CD8+ T lymphocyte content may be associated with adverse clinical outcomes, and a decrease in CD4+ T lymphocyte content and a decrease in the CD4+/CD8+ ratio indicate that CRC is in a progressive state and undergoing accelerated proliferation (63). The gene discussed is CD4; the disease is colorectal carcinoma.